Bausch Health Companies Inc. (NASDAQ:BHC) | Finanzwire

Basculer en Français

9478	Companies
185492	Keywords
117871	Articles
99349	Press releases

Headlines Articles Press releases Bausch Health Companies Inc.

Home
Companies
Bausch Health Companies Inc.

PRESS RELEASE

published on 04/02/2024 at 14:00, 1 year 8 months ago

Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
Salix Pharmaceuticals releases fourth annual Patient Perspectives IBS Impact Report, revealing insights on the experiences of IBS/CIC patients and the need for more authentic conversations. Survey conducted in partnership with FDU Poll

Salix Pharmaceuticals IBS Impact Report FDU Poll Patient Experiences Authentic Conversations
BRIEF

published on 03/06/2024 at 14:05, 1 year 8 months ago

Salix Pharmaceuticals Backs Phase 2 Study on RELISTOR for Head and Neck Cancer

Salix Pharmaceuticals Clinical Trial Phase 2 Study RELISTOR Head And Neck Cancer
PRESS RELEASE

published on 03/06/2024 at 14:00, 1 year 8 months ago

Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
Bausch Health Companies Inc. and Salix Pharmaceuticals are supporting a Phase 2 study of RELISTOR in head and neck cancer patients. The study aims to evaluate the potential of methylnaltrexone bromide as a treatment option

Bausch Health Companies Inc. Salix Pharmaceuticals Phase 2 Study RELISTOR Head And Neck Cancer
BRIEF

published on 03/05/2024 at 14:05, 1 year 9 months ago

Survey Reveals Colonoscopy Preparation Concerns Among U.S. Patients

Salix Pharmaceuticals Colonoscopy Patient Awareness Survey Results Preparation Process
PRESS RELEASE

published on 03/05/2024 at 14:00, 1 year 9 months ago

New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
Salix Pharmaceuticals releases findings from first colonoscopy awareness survey, revealing insights on patient perspectives, barriers, and healthcare provider recommendations

Salix Pharmaceuticals Colonoscopy Awareness Healthcare Provider Patient Perspectives Barriers
BRIEF

published on 03/01/2024 at 14:05, 1 year 9 months ago

Bausch Health Companies to Present at Cowen Annual Health Care Conference

Investor Relations Webcast Bausch Health Health Care Conference Cowen Annual
PRESS RELEASE

published on 03/01/2024 at 14:00, 1 year 9 months ago

Bausch Health Companies to Present at Cowen Annual Health Care Conference
Bausch Health Companies Inc. to participate in Cowen Annual Health Care Conference on March 5, 2024, hosting a fireside chat. Webcast details provided

Bausch Health Companies Inc. Investor Relations Webcast Fireside Chat Cowen Annual Health Care Conference
PRESS RELEASE

published on 02/12/2024 at 14:00, 1 year 9 months ago

Salix Announces 2024 Gastrointestinal Health Scholars Program
Bausch Health Companies Inc. has announced the 2024 Salix Gastrointestinal Health Scholars Program, offering scholarships of up to $10,000 to 10 students with GI diseases. Applications open until May 6, 2024. Learn more at www.salix.com/scholarship

Bausch Health Companies Inc. Financial Support Salix Gastrointestinal Health Scholars Program Scholarships GI Diseases
PRESS RELEASE

published on 02/01/2024 at 22:10, 1 year 10 months ago

Bausch Health Announces Board Refreshment
Bausch Health Companies Inc. nominates two independent and diverse candidates, Christian A. Garcia and Frank D. Lee, for election to its Board of Directors. Russel C. Robertson and Thomas W. Ross, Sr. will retire from the Board, and the new nominees are expected to fill their roles. Bausch Health's 2024 Annual Meeting details will be included in the proxy statement

Bausch Health Companies Inc. 2024 Annual Meeting Proxy Statement Board Refreshment Diverse Candidates
PRESS RELEASE

published on 02/01/2024 at 14:00, 1 year 10 months ago

Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
Bausch Health Companies Inc. (NYSE/TSX:BHC) will release Q4 and full-year 2023 financial results on Feb. 22, 2024, followed by a conference call and webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update

Financial Results Conference Call Bausch Health Companies Inc. Investor Relations Webcast

Accesswire

Published on 12/05/2025 at 16:00, 33 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 48 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 58 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 1 hour 8 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 1 hour 33 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 16:25, 8 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 23 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 33 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 33 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 33 minutes ago

Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 15:10, 1 hour 22 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 7 hours 48 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 22 hours 33 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 22 hours 48 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 22 hours 49 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

View all LES ECHOS COMFI WIRE